Background: Non-alcoholic fatty liver disease (NAFLD) is becoming a major health problem, resulting in hepatic, metabolic and cardio-vascular morbidity.
Aim: To evaluate new ultrasonographic tools to detect and measure hepatic steatosis.
Methods: We prospectively included 105 patients referred to our liver unit for NAFLD suspicion or follow-up.